About the Product

Description


Piquin 45 Tablet containing Primaquine is used for the management and prevention of relapse in certain forms of malaria. It helps eliminate dormant liver-stage malaria parasites and supports comprehensive malaria treatment.

Primaquine works as an antimalarial agent that targets hepatic forms of malaria parasites, particularly dormant stages responsible for recurrent infections, thereby helping reduce the likelihood of relapse.

The tablet is widely utilized in infectious disease and general medicine practice as part of malaria management protocols, leading to consistent demand in regions where malaria remains a public health concern.

With ongoing efforts to control malaria and increasing emphasis on complete parasite eradication, this product offers strong business potential for retailers and distributors. Its established therapeutic role, proven clinical relevance, and steady market demand make it a reliable product for growth in the anti-infective segment.

Some patients may experience nausea, vomiting, abdominal discomfort, headache, dizziness, or loss of appetite. Rarely, hemolytic anemia, methemoglobinemia, severe allergic reactions, or blood disorders may occur and require immediate medical attention.

Piquin 45 Tablet is indicated for the radical cure of Plasmodium vivax and Plasmodium ovale malaria, prevention of malaria relapse, and as part of combination therapy for certain malaria infections as prescribed by a healthcare professional. It helps eliminate dormant liver-stage parasites and reduce the risk of recurrent infection.

This medicine should be used strictly under medical supervision. Screening for glucose-6-phosphate dehydrogenase (G6PD) deficiency is recommended before initiating Primaquine therapy, as the medicine may cause severe hemolysis in G6PD-deficient individuals. Use cautiously in patients with anemia, blood disorders, or liver impairment. Follow the prescribed dosage and treatment duration carefully.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Primaquine 45mg Tablet in the PCD pharma franchise market?

Primaquine 45mg Tablet has demand in the anti-malarial, infectious disease, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-infective and tropical disease management portfolios.

Why should medical distributors include Primaquine 45mg Tablet in their product range?

Medical distributors and agencies can benefit from demand for malaria management under medical supervision. Primaquine 45mg is an antimalarial medication used as part of treatment protocols for certain types of malaria Commonly prescribed for the radical cure and prevention of relapse of Plasmodium vivax and Plasmodium ovale malaria, as directed by healthcare professionals Plays an important role in malaria control programs and infectious disease management Widely used in hospitals, clinics, and healthcare facilities where malaria treatment is required This strengthens a comprehensive anti-infective and tropical disease care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Primaquine 45mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from demand in infectious disease management, institutional supply opportunities, reliable supply chain support, and attractive margins in the anti-malarial segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.